APA (7th ed.) Citation

H, K., ZM, D., C, O., N, B., RE, R., DY, W., . . . SA, G. (2020). Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS). Case reports in hematology, 2020, 8811673. https://doi.org/10.1155/2020/8811673

Chicago Style (17th ed.) Citation

H, Klocke, Dong ZM, O'Brien C, Burwick N, Richard RE, Wu DY, Chauncey TR, and Graf SA. "Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)." Case Reports in Hematology 2020 (2020): 8811673. https://doi.org/10.1155/2020/8811673.

MLA (9th ed.) Citation

H, Klocke, et al. "Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)." Case Reports in Hematology, vol. 2020, 2020, p. 8811673, https://doi.org/10.1155/2020/8811673.